DIGITAL BIOMARKERS MARKET ANALYSIS

Digital Biomarkers Market, By Data Collection Tools ((Wearable Devices, Implantable Components/Sensors, Mobile/Tablet Apps, Platforms, Desktop Based Software, and Data Integration (Systems that Integrate Data)), By Application (Sleep and Movement, Cardiovascular Disease, Mood and Behavior, Pain Management, Neurodegenerative Disorders, and Respiratory Conditions), and By End User (Biopharmaceutical Companies, Providers, and Payers), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Jun 2023
Code : CMI5884
Pages :155
Formats :
Excel and PDF
Industry : Healthcare IT

Leading Companies

Companies covered:

AliveCor Inc., Altoida Inc., Amgen Inc., Human API, Fitbit, Inc., Biogen Inc, Bayer AG, Akili Interactive Labs, Evidation Health, Inc., GlaxoSmithKline Plc, and Eli Lilly and Company, among others.

Global Digital Biomarkers Market: Key Companies Insights

The digital biomarkers market is highly competitive. This is attributed to the increasing number of clinical trials, as a result, players in the market are focusing on developing and launching novel products in the market.

Some of the key players in the global digital biomarkers market are AliveCor Inc., Altoida Inc., Amgen Inc., Human API, Fitbit, Inc., Biogen Inc, Bayer AG, Akili Interactive Labs, Evidation Health, Inc., GlaxoSmithKline Plc, and Eli Lilly and Company, among others.

Digital Biomarkers Market Report Snapshots

DIGITAL BIOMARKERS MARKET ANALYSIS

Leading Companies

EXISTING CLIENTELE